Long-term changes in adiposity markers during and after antidepressant therapy in a community cohort
Research on antidepressant-related weight changes over more than 12 months is scarce and adjustment for the effects of depressive episodes has rarely been applied. Accordingly, our aim was to assess the associations of the use of any antidepressants, subclasses of antidepressant and specific compoun...
Saved in:
Published in | Translational psychiatry Vol. 14; no. 1; pp. 330 - 13 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
13.08.2024
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Research on antidepressant-related weight changes over more than 12 months is scarce and adjustment for the effects of depressive episodes has rarely been applied. Accordingly, our aim was to assess the associations of the use of any antidepressants, subclasses of antidepressant and specific compounds prior to baseline and during a 5.5-year follow-up with changes in adiposity markers, and the effect of sex on these associations, with adjustment for multiple confounders including the effects of depressive episodes and their severity. Data stemmed from a prospective cohort study including 2479 randomly selected 35–66 year-old residents of an urban area (mean age 49.9 years, 53.3% women) who underwent physical and psychiatric evaluations at baseline and follow-up. Weight, height, waist circumference, and body fat were measured by trained nurses and information on diagnosis and antidepressant use prior to baseline and during follow-up was collected through standardized interviews. In the fully adjusted models, the number of antidepressants, mainly SSRIs and TCAs, used prior to baseline, was associated with a lower increase of body-mass index (BMI, β (95%CI) = −0.12 (−0.19, −0.05)) and waist circumference (β = −0.28 (−0.56, −0.01)), whereas participants treated with antidepressants during the follow-up had a steeper increase in BMI (β = 0.32 (0.13, 0.50)) and waist circumference (β = 1.23 (0.44, 2.01)). Within the class of SSRIs, the use of fluoxetine, sertraline or escitalopram during follow-up was associated with a steeper increase in adiposity markers. The associations of SSRIs with BMI and waist circumference were only observed when the SSRIs were used during the second period of the follow-up. Sex did not moderate these associations. Our findings suggest an increase of adiposity markers during sustained treatment with TCAs and SSRIs, which however return to normal levels after cessation of treatment. Hence, the benefit of long-term administration of these antidepressants should be carefully weighed against the potential risk of weight gain. |
---|---|
AbstractList | Research on antidepressant-related weight changes over more than 12 months is scarce and adjustment for the effects of depressive episodes has rarely been applied. Accordingly, our aim was to assess the associations of the use of any antidepressants, subclasses of antidepressant and specific compounds prior to baseline and during a 5.5-year follow-up with changes in adiposity markers, and the effect of sex on these associations, with adjustment for multiple confounders including the effects of depressive episodes and their severity. Data stemmed from a prospective cohort study including 2479 randomly selected 35–66 year-old residents of an urban area (mean age 49.9 years, 53.3% women) who underwent physical and psychiatric evaluations at baseline and follow-up. Weight, height, waist circumference, and body fat were measured by trained nurses and information on diagnosis and antidepressant use prior to baseline and during follow-up was collected through standardized interviews. In the fully adjusted models, the number of antidepressants, mainly SSRIs and TCAs, used prior to baseline, was associated with a lower increase of body-mass index (BMI, β (95%CI) = −0.12 (−0.19, −0.05)) and waist circumference (β = −0.28 (−0.56, −0.01)), whereas participants treated with antidepressants during the follow-up had a steeper increase in BMI (β = 0.32 (0.13, 0.50)) and waist circumference (β = 1.23 (0.44, 2.01)). Within the class of SSRIs, the use of fluoxetine, sertraline or escitalopram during follow-up was associated with a steeper increase in adiposity markers. The associations of SSRIs with BMI and waist circumference were only observed when the SSRIs were used during the second period of the follow-up. Sex did not moderate these associations. Our findings suggest an increase of adiposity markers during sustained treatment with TCAs and SSRIs, which however return to normal levels after cessation of treatment. Hence, the benefit of long-term administration of these antidepressants should be carefully weighed against the potential risk of weight gain. Abstract Research on antidepressant-related weight changes over more than 12 months is scarce and adjustment for the effects of depressive episodes has rarely been applied. Accordingly, our aim was to assess the associations of the use of any antidepressants, subclasses of antidepressant and specific compounds prior to baseline and during a 5.5-year follow-up with changes in adiposity markers, and the effect of sex on these associations, with adjustment for multiple confounders including the effects of depressive episodes and their severity. Data stemmed from a prospective cohort study including 2479 randomly selected 35–66 year-old residents of an urban area (mean age 49.9 years, 53.3% women) who underwent physical and psychiatric evaluations at baseline and follow-up. Weight, height, waist circumference, and body fat were measured by trained nurses and information on diagnosis and antidepressant use prior to baseline and during follow-up was collected through standardized interviews. In the fully adjusted models, the number of antidepressants, mainly SSRIs and TCAs, used prior to baseline, was associated with a lower increase of body-mass index (BMI, β (95%CI) = −0.12 (−0.19, −0.05)) and waist circumference (β = −0.28 (−0.56, −0.01)), whereas participants treated with antidepressants during the follow-up had a steeper increase in BMI (β = 0.32 (0.13, 0.50)) and waist circumference (β = 1.23 (0.44, 2.01)). Within the class of SSRIs, the use of fluoxetine, sertraline or escitalopram during follow-up was associated with a steeper increase in adiposity markers. The associations of SSRIs with BMI and waist circumference were only observed when the SSRIs were used during the second period of the follow-up. Sex did not moderate these associations. Our findings suggest an increase of adiposity markers during sustained treatment with TCAs and SSRIs, which however return to normal levels after cessation of treatment. Hence, the benefit of long-term administration of these antidepressants should be carefully weighed against the potential risk of weight gain. Research on antidepressant-related weight changes over more than 12 months is scarce and adjustment for the effects of depressive episodes has rarely been applied. Accordingly, our aim was to assess the associations of the use of any antidepressants, subclasses of antidepressant and specific compounds prior to baseline and during a 5.5-year follow-up with changes in adiposity markers, and the effect of sex on these associations, with adjustment for multiple confounders including the effects of depressive episodes and their severity. Data stemmed from a prospective cohort study including 2479 randomly selected 35-66 year-old residents of an urban area (mean age 49.9 years, 53.3% women) who underwent physical and psychiatric evaluations at baseline and follow-up. Weight, height, waist circumference, and body fat were measured by trained nurses and information on diagnosis and antidepressant use prior to baseline and during follow-up was collected through standardized interviews. In the fully adjusted models, the number of antidepressants, mainly SSRIs and TCAs, used prior to baseline, was associated with a lower increase of body-mass index (BMI, β (95%CI) = -0.12 (-0.19, -0.05)) and waist circumference (β = -0.28 (-0.56, -0.01)), whereas participants treated with antidepressants during the follow-up had a steeper increase in BMI (β = 0.32 (0.13, 0.50)) and waist circumference (β = 1.23 (0.44, 2.01)). Within the class of SSRIs, the use of fluoxetine, sertraline or escitalopram during follow-up was associated with a steeper increase in adiposity markers. The associations of SSRIs with BMI and waist circumference were only observed when the SSRIs were used during the second period of the follow-up. Sex did not moderate these associations. Our findings suggest an increase of adiposity markers during sustained treatment with TCAs and SSRIs, which however return to normal levels after cessation of treatment. Hence, the benefit of long-term administration of these antidepressants should be carefully weighed against the potential risk of weight gain. Research on antidepressant-related weight changes over more than 12 months is scarce and adjustment for the effects of depressive episodes has rarely been applied. Accordingly, our aim was to assess the associations of the use of any antidepressants, subclasses of antidepressant and specific compounds prior to baseline and during a 5.5-year follow-up with changes in adiposity markers, and the effect of sex on these associations, with adjustment for multiple confounders including the effects of depressive episodes and their severity. Data stemmed from a prospective cohort study including 2479 randomly selected 35-66 year-old residents of an urban area (mean age 49.9 years, 53.3% women) who underwent physical and psychiatric evaluations at baseline and follow-up. Weight, height, waist circumference, and body fat were measured by trained nurses and information on diagnosis and antidepressant use prior to baseline and during follow-up was collected through standardized interviews. In the fully adjusted models, the number of antidepressants, mainly SSRIs and TCAs, used prior to baseline, was associated with a lower increase of body-mass index (BMI, β (95%CI) = -0.12 (-0.19, -0.05)) and waist circumference (β = -0.28 (-0.56, -0.01)), whereas participants treated with antidepressants during the follow-up had a steeper increase in BMI (β = 0.32 (0.13, 0.50)) and waist circumference (β = 1.23 (0.44, 2.01)). Within the class of SSRIs, the use of fluoxetine, sertraline or escitalopram during follow-up was associated with a steeper increase in adiposity markers. The associations of SSRIs with BMI and waist circumference were only observed when the SSRIs were used during the second period of the follow-up. Sex did not moderate these associations. Our findings suggest an increase of adiposity markers during sustained treatment with TCAs and SSRIs, which however return to normal levels after cessation of treatment. Hence, the benefit of long-term administration of these antidepressants should be carefully weighed against the potential risk of weight gain.Research on antidepressant-related weight changes over more than 12 months is scarce and adjustment for the effects of depressive episodes has rarely been applied. Accordingly, our aim was to assess the associations of the use of any antidepressants, subclasses of antidepressant and specific compounds prior to baseline and during a 5.5-year follow-up with changes in adiposity markers, and the effect of sex on these associations, with adjustment for multiple confounders including the effects of depressive episodes and their severity. Data stemmed from a prospective cohort study including 2479 randomly selected 35-66 year-old residents of an urban area (mean age 49.9 years, 53.3% women) who underwent physical and psychiatric evaluations at baseline and follow-up. Weight, height, waist circumference, and body fat were measured by trained nurses and information on diagnosis and antidepressant use prior to baseline and during follow-up was collected through standardized interviews. In the fully adjusted models, the number of antidepressants, mainly SSRIs and TCAs, used prior to baseline, was associated with a lower increase of body-mass index (BMI, β (95%CI) = -0.12 (-0.19, -0.05)) and waist circumference (β = -0.28 (-0.56, -0.01)), whereas participants treated with antidepressants during the follow-up had a steeper increase in BMI (β = 0.32 (0.13, 0.50)) and waist circumference (β = 1.23 (0.44, 2.01)). Within the class of SSRIs, the use of fluoxetine, sertraline or escitalopram during follow-up was associated with a steeper increase in adiposity markers. The associations of SSRIs with BMI and waist circumference were only observed when the SSRIs were used during the second period of the follow-up. Sex did not moderate these associations. Our findings suggest an increase of adiposity markers during sustained treatment with TCAs and SSRIs, which however return to normal levels after cessation of treatment. Hence, the benefit of long-term administration of these antidepressants should be carefully weighed against the potential risk of weight gain. Research on antidepressant-related weight changes over more than 12 months is scarce and adjustment for the effects of depressive episodes has rarely been applied. Accordingly, our aim was to assess the associations of the use of any antidepressants, subclasses of antidepressant and specific compounds prior to baseline and during a 5.5-year follow-up with changes in adiposity markers, and the effect of sex on these associations, with adjustment for multiple confounders including the effects of depressive episodes and their severity. Data stemmed from a prospective cohort study including 2479 randomly selected 35-66 year-old residents of an urban area (mean age 49.9 years, 53.3% women) who underwent physical and psychiatric evaluations at baseline and follow-up. Weight, height, waist circumference, and body fat were measured by trained nurses and information on diagnosis and antidepressant use prior to baseline and during follow-up was collected through standardized interviews. In the fully adjusted models, the number of antidepressants, mainly SSRIs and TCAs, used prior to baseline, was associated with a lower increase of body-mass index (BMI, beta (95%CI) = -0.12 (-0.19, -0.05)) and waist circumference (beta = -0.28 (-0.56, -0.01)), whereas participants treated with antidepressants during the follow-up had a steeper increase in BMI (beta = 0.32 (0.13, 0.50)) and waist circumference (beta = 1.23 (0.44, 2.01)). Within the class of SSRIs, the use of fluoxetine, sertraline or escitalopram during follow-up was associated with a steeper increase in adiposity markers. The associations of SSRIs with BMI and waist circumference were only observed when the SSRIs were used during the second period of the follow-up. Sex did not moderate these associations. Our findings suggest an increase of adiposity markers during sustained treatment with TCAs and SSRIs, which however return to normal levels after cessation of treatment. Hence, the benefit of long-term administration of these antidepressants should be carefully weighed against the potential risk of weight gain. |
ArticleNumber | 330 |
Author | Kanders, Sofia H. Mwinyi, Jessica Strippoli, Marie-Pierre F. Marques-Vidal, Pedro Lasserre, Aurélie M. Schiöth, Helgi B. Eap, Chin B. Vandeleur, Caroline L. Preisig, Martin |
Author_xml | – sequence: 1 givenname: Jessica surname: Mwinyi fullname: Mwinyi, Jessica organization: Department of Surgical Sciences, Uppsala University – sequence: 2 givenname: Marie-Pierre F. orcidid: 0000-0003-3053-484X surname: Strippoli fullname: Strippoli, Marie-Pierre F. email: marie-pierre.strippoli@chuv.ch organization: Psychiatric Epidemiology and Psychopathology Research Center, Department of Psychiatry, Lausanne University Hospital and University of Lausanne – sequence: 3 givenname: Sofia H. orcidid: 0000-0002-5795-8100 surname: Kanders fullname: Kanders, Sofia H. organization: Department of Surgical Sciences, Uppsala University, Centre for Clinical Research, Region Västmanland, Uppsala University – sequence: 4 givenname: Helgi B. orcidid: 0000-0001-7112-0921 surname: Schiöth fullname: Schiöth, Helgi B. organization: Department of Surgical Sciences, Uppsala University – sequence: 5 givenname: Chin B. orcidid: 0000-0002-5439-0230 surname: Eap fullname: Eap, Chin B. organization: School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Center for Research and Innovation in Clinical Pharmaceutical Sciences, University of Lausanne, Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne – sequence: 6 givenname: Aurélie M. orcidid: 0000-0003-3925-6663 surname: Lasserre fullname: Lasserre, Aurélie M. organization: Addiction Medicine, Department of Psychiatry, Lausanne University Hospital and University of Lausanne – sequence: 7 givenname: Pedro surname: Marques-Vidal fullname: Marques-Vidal, Pedro organization: Internal Medicine, Department of Medicine, Lausanne University Hospital and University of Lausanne – sequence: 8 givenname: Caroline L. orcidid: 0000-0001-9092-6648 surname: Vandeleur fullname: Vandeleur, Caroline L. organization: Psychiatric Epidemiology and Psychopathology Research Center, Department of Psychiatry, Lausanne University Hospital and University of Lausanne – sequence: 9 givenname: Martin orcidid: 0000-0001-5689-4259 surname: Preisig fullname: Preisig, Martin organization: Psychiatric Epidemiology and Psychopathology Research Center, Department of Psychiatry, Lausanne University Hospital and University of Lausanne |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39138155$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-537254$$DView record from Swedish Publication Index |
BookMark | eNp9kstu1DAUhi1URMvQF2CBIrFhQcCXOIlXqGq5VBqJDbC1HPsk42FiBzspmrevJxlKhwXe-Mj-zn8u-p-jM-cdIPSS4HcEs_p9LAgTdY5pkWOGGc35E3RBCa9zRur67FF8ji5j3OJ0eFGTijxD50wQVhPOL5BZe9flI4Q-0xvlOoiZdZkydvDRjvusV-EnhJiZKVjXZcqZTLUJT9FoDQwBYkxhNm4gqGE_J2fa9_3kDunab3wYX6CnrdpFuDzeK_T908dv11_y9dfPt9dX61wXXIw5JQKgpFqXdVXgooKWY9qySpGClZQb3lJRC6XakjOly0aXlCgBVOOCYiMoW6HbRdd4tZVDsKn7vfTKyvnBh06qMFq9A9kQQkoNtCxNqkW5aqAxAphoU6gYJK23i1b8DcPUnKjd2B9Xs9o0Sc4qyouEf1jwxPZgNLgxqN1J1umPsxvZ-TtJCKOUU5IU3hwVgv81QRxlb6OG3U458FOUDAtalwKLQ7HX_6BbPwWXVjtTHONCiETRhdLBxxigfeiGYHnwkFw8JJOH5OyhNMwKvXo8x0PKH8ckgB33MhwcAeFv7f_I3gOeodSJ |
Cites_doi | 10.1016/j.ajp.2015.12.008 10.1159/000209349 10.4088/JCP.09r05346blu 10.1016/S0376-8716(01)00156-9 10.1038/sj.bjp.0707253 10.1001/jamapsychiatry.2014.414 10.1001/jamapsychiatry.2014.411 10.1017/S1461145710000933 10.2217/pgs.09.102 10.1002/hup.388 10.3390/jcm5040048 10.1155/2011/893629 10.1038/tp.2016.25 10.3399/bjgp11X593848 10.1016/0306-4522(95)00566-8 10.1097/01.jcp.0000095341.32154.8f 10.4088/JCP.v62n0407 10.1186/1471-2261-8-6 10.1001/archpsyc.1978.01770310043002 10.1016/0165-1781(88)90120-5 10.1136/bmj.k1951 10.1002/da.22963 10.1186/1471-244X-9-9 10.1176/ajp.156.8.1170 10.1007/s12471-011-0237-7 10.1001/archpsyc.1977.01770220111013 10.1111/obr.12934 10.1007/s004060050084 10.1001/archgenpsychiatry.2010.2 10.1038/oby.2004.131 10.1038/sj.ijo.0803475 10.31887/DCNS.2016.18.4/ncutler 10.1001/archpsyc.1994.03950110009002 10.1210/jc.2014-3421 10.4088/JCP.13m08896 10.2337/dc10-1187 10.1192/bjp.bp.114.153098 10.1016/j.euroneuro.2013.05.001 10.1016/0165-0327(84)90031-4 10.1001/jama.2016.3445 10.1007/BF02219716 10.31887/DCNS.2018.20.1/bpenninx |
ContentType | Journal Article |
Copyright | The Author(s) 2024 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024 2024 |
Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024 2024 |
DBID | C6C CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM ACNBI ADTPV AOWAS D8T DF2 ZZAVC DOA |
DOI | 10.1038/s41398-024-03032-5 |
DatabaseName | SpringerOpen Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest - Health & Medical Complete保健、医学与药学数据库 ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) SWEPUB Uppsala universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Uppsala universitet SwePub Articles full text Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: C6C name: Springer_OA刊 url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 7X7 name: PHMC-Proquest健康医学期刊库 url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2158-3188 |
EndPage | 13 |
ExternalDocumentID | oai_doaj_org_article_b1116ce266d74025abebd9e39f5aba3e oai_DiVA_org_uu_537254 10_1038_s41398_024_03032_5 39138155 |
Genre | Journal Article |
GrantInformation_xml | – fundername: GlaxoSmithKline (GlaxoSmithKline plc.) funderid: https://doi.org/10.13039/100004330 – fundername: Faculty of Biology and Medicine of Lausanne, Swiss Personalized Health Network (grant 2018DRI01) |
GroupedDBID | --- 0R~ 3V. 53G 5VS 7X7 88E 8FI 8FJ AAJSJ AAKDD ABUWG ACGFO ACGFS ACMJI ACSMW ADBBV ADFRT AENEX AFKRA AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS BAWUL BCNDV BENPR BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EMOBN FYUFA GROUPED_DOAJ GX1 HMCUK HYE KQ8 LGEZI LOTEE M1P M~E NADUK NAO NXXTH OK1 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT UKHRP CGR CUY CVF ECM EIF NPM AAYXX CITATION 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 7X8 5PM 4.4 ACNBI ADTPV AOWAS BAPOH D8T DF2 EJD ZZAVC |
ID | FETCH-LOGICAL-c459t-219ee62cc6874047ef502f37a143625d5f2989aaf653ac6bc621a9e2c0420d923 |
IEDL.DBID | RPM |
ISSN | 2158-3188 |
IngestDate | Tue Oct 22 15:17:01 EDT 2024 Tue Sep 03 03:27:49 EDT 2024 Tue Sep 17 21:27:27 EDT 2024 Tue Aug 27 04:54:49 EDT 2024 Thu Oct 10 22:22:49 EDT 2024 Fri Aug 23 04:16:27 EDT 2024 Wed Oct 23 09:25:36 EDT 2024 Fri Oct 11 20:51:43 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c459t-219ee62cc6874047ef502f37a143625d5f2989aaf653ac6bc621a9e2c0420d923 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-3925-6663 0000-0001-5689-4259 0000-0002-5439-0230 0000-0003-3053-484X 0000-0002-5795-8100 0000-0001-9092-6648 0000-0001-7112-0921 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11322521/ |
PMID | 39138155 |
PQID | 3092500499 |
PQPubID | 2041978 |
PageCount | 13 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b1116ce266d74025abebd9e39f5aba3e swepub_primary_oai_DiVA_org_uu_537254 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11322521 proquest_miscellaneous_3092869094 proquest_journals_3092500499 crossref_primary_10_1038_s41398_024_03032_5 pubmed_primary_39138155 springer_journals_10_1038_s41398_024_03032_5 |
PublicationCentury | 2000 |
PublicationDate | 2024-08-13 |
PublicationDateYYYYMMDD | 2024-08-13 |
PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-13 day: 13 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: United States |
PublicationTitle | Translational psychiatry |
PublicationTitleAbbrev | Transl Psychiatry |
PublicationTitleAlternate | Transl Psychiatry |
PublicationYear | 2024 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Leboyer, Maier, Teherani, Lichtermann, D’Amato, Franke (CR32) 1991; 241 Uher, Mors, Hauser, Rietschel, Maier, Kozel (CR9) 2011; 14 Haack, Seeringer, Thurmann, Becker, Kirchheiner (CR19) 2009; 10 Bet, Hugtenburg, Penninx, Hoogendijk (CR21) 2013; 23 Preisig, Waeber, Vollenweider, Bovet, Rothen, Vandeleur (CR24) 2009; 9 Noordam, Aarts, Tiemeier, Hofman, Stricker, Visser (CR22) 2015; 76 Blumenthal, Castro, Clements, Rosenfield, Murphy, Fava (CR40) 2014; 71 Lamers, Beekman, van Hemert, Schoevers, Penninx (CR15) 2016; 208 Gafoor, Booth, Gulliford (CR13) 2018; 361 van Dijk, Takken, Prinsen, Wittink (CR17) 2012; 20 Nihalani, Schwartz, Siddiqui, Megna (CR43) 2011; 2011 Lasserre, Glaus, Vandeleur, Marques-Vidal, Vaucher, Bastardot (CR16) 2014; 71 CR33 Nutt (CR39) 2002; 17 Arterburn, Sofer, Boudreau, Bogart, Westbrook, Theis (CR41) 2016; 5 Firmann, Mayor, Vidal, Bochud, Pecoud, Hayoz (CR23) 2008; 8 Preisig, Fenton, Matthey, Berney, Ferrero (CR30) 1999; 249 Kivimaki, Hamer, Batty, Geddes, Tabak, Pentti (CR38) 2010; 33 Nurnberger, Blehar, Kaufmann, York-Cooler, Simpson, Harkavy-Friedman (CR28) 1994; 51 Patten, Williams, Lavorato, Brown, McLaren, Eliasziw (CR14) 2009; 78 Jebb, Siervo, Murgatroyd, Evans, Fruhbeck, Prentice (CR25) 2007; 31 Berken, Weinstein, Stern (CR35) 1984; 7 Berney, Preisig, Matthey, Ferrero, Fenton (CR29) 2002; 65 Mannan, Mamun, Doi, Clavarino (CR4) 2016; 21 Sramek, Murphy, Cutler (CR20) 2016; 18 Serretti, Mandelli (CR10) 2010; 71 Dryden, Frankish, Wang, Pickavance, Williams (CR45) 1996; 72 CR27 Lockhart, Guthrie (CR5) 2011; 61 CR26 Domecq, Prutsky, Leppin, Sonbol, Altayar, Undavalli (CR11) 2015; 100 Penninx, Lange (CR1) 2018; 20 Lee, Paz-Filho, Mastronardi, Licinio, Wong (CR7) 2016; 6 Mulugeta, Zhou, Vimaleswaran, Dickson, Hypponen (CR2) 2019; 36 Wong, Motulsky, Eguale, Buckeridge, Abrahamowicz, Tamblyn (CR6) 2016; 315 Luppino, de Wit, Bouvy, Stijnen, Cuijpers, Penninx (CR3) 2010; 67 Alonso-Pedrero, Bes-Rastrollo, Marti (CR12) 2019; 20 Michelson, Amsterdam, Quitkin, Reimherr, Rosenbaum, Zajecka (CR37) 1999; 156 Sussman, Ginsberg, Bikoff (CR36) 2001; 62 Andreasen, Endicott, Spitzer, Winokur (CR34) 1977; 34 Gillman (CR42) 2007; 151 Endicott, Spitzer (CR31) 1978; 35 Fernstrom, Kupfer (CR8) 1988; 26 Bigaard, Frederiksen, Tjonneland, Thomsen, Overvad, Heitmann (CR18) 2004; 12 Moosa, Panz, Jeenah, Joffe (CR44) 2003; 23 M Kivimaki (3032_CR38) 2010; 33 SB van Dijk (3032_CR17) 2012; 20 M Preisig (3032_CR24) 2009; 9 A Mulugeta (3032_CR2) 2019; 36 PM Bet (3032_CR21) 2013; 23 F Lamers (3032_CR15) 2016; 208 M Leboyer (3032_CR32) 1991; 241 JJ Sramek (3032_CR20) 2016; 18 M Firmann (3032_CR23) 2008; 8 GH Berken (3032_CR35) 1984; 7 R Noordam (3032_CR22) 2015; 76 A Berney (3032_CR29) 2002; 65 D Michelson (3032_CR37) 1999; 156 J Wong (3032_CR6) 2016; 315 N Nihalani (3032_CR43) 2011; 2011 S Haack (3032_CR19) 2009; 10 J Endicott (3032_CR31) 1978; 35 MY Moosa (3032_CR44) 2003; 23 D Arterburn (3032_CR41) 2016; 5 FS Luppino (3032_CR3) 2010; 67 R Uher (3032_CR9) 2011; 14 3032_CR33 MH Fernstrom (3032_CR8) 1988; 26 J Bigaard (3032_CR18) 2004; 12 JI Nurnberger Jr (3032_CR28) 1994; 51 P Lockhart (3032_CR5) 2011; 61 S Dryden (3032_CR45) 1996; 72 SH Lee (3032_CR7) 2016; 6 SB Patten (3032_CR14) 2009; 78 M Mannan (3032_CR4) 2016; 21 R Gafoor (3032_CR13) 2018; 361 N Sussman (3032_CR36) 2001; 62 SR Blumenthal (3032_CR40) 2014; 71 PK Gillman (3032_CR42) 2007; 151 AM Lasserre (3032_CR16) 2014; 71 3032_CR27 A Serretti (3032_CR10) 2010; 71 SA Jebb (3032_CR25) 2007; 31 3032_CR26 DJ Nutt (3032_CR39) 2002; 17 B Penninx (3032_CR1) 2018; 20 NC Andreasen (3032_CR34) 1977; 34 JP Domecq (3032_CR11) 2015; 100 L Alonso-Pedrero (3032_CR12) 2019; 20 M Preisig (3032_CR30) 1999; 249 |
References_xml | – volume: 21 start-page: 51 year: 2016 end-page: 66 ident: CR4 article-title: Is there a bi-directional relationship between depression and obesity among adult men and women? Systematic review and bias-adjusted meta analysis publication-title: Asian J Psychiatry doi: 10.1016/j.ajp.2015.12.008 contributor: fullname: Clavarino – volume: 78 start-page: 182 year: 2009 end-page: 6 ident: CR14 article-title: Major depression, antidepressant medication and the risk of obesity publication-title: Psychother Psychosom doi: 10.1159/000209349 contributor: fullname: Eliasziw – volume: 71 start-page: 1259 year: 2010 end-page: 72 ident: CR10 article-title: Antidepressants and body weight: a comprehensive review and meta-analysis publication-title: J Clin Psychiatry doi: 10.4088/JCP.09r05346blu contributor: fullname: Mandelli – volume: 65 start-page: 149 year: 2002 end-page: 58 ident: CR29 article-title: Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of alcohol and drug diagnoses publication-title: Drug Alcohol Depend doi: 10.1016/S0376-8716(01)00156-9 contributor: fullname: Fenton – volume: 151 start-page: 737 year: 2007 end-page: 48 ident: CR42 article-title: Tricyclic antidepressant pharmacology and therapeutic drug interactions updated publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0707253 contributor: fullname: Gillman – volume: 71 start-page: 889 year: 2014 end-page: 96 ident: CR40 article-title: An electronic health records study of long-term weight gain following antidepressant use publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2014.414 contributor: fullname: Fava – volume: 71 start-page: 880 year: 2014 end-page: 8 ident: CR16 article-title: Depression with atypical features and increase in obesity, body mass index, waist circumference, and fat mass: a prospective, population-based study publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2014.411 contributor: fullname: Bastardot – volume: 14 start-page: 367 year: 2011 end-page: 75 ident: CR9 article-title: Changes in body weight during pharmacological treatment of depression publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145710000933 contributor: fullname: Kozel – volume: 10 start-page: 1511 year: 2009 end-page: 26 ident: CR19 article-title: Sex-specific differences in side effects of psychotropic drugs: genes or gender? publication-title: Pharmacogenomics doi: 10.2217/pgs.09.102 contributor: fullname: Kirchheiner – ident: CR33 – volume: 17 start-page: S37 issue: Suppl 1 year: 2002 end-page: 41 ident: CR39 article-title: Tolerability and safety aspects of mirtazapine publication-title: Hum Psychopharmacol doi: 10.1002/hup.388 contributor: fullname: Nutt – volume: 5 start-page: 48 year: 2016 ident: CR41 article-title: Long-term weight change after initiating second-generation antidepressants publication-title: J Clin Med doi: 10.3390/jcm5040048 contributor: fullname: Theis – volume: 2011 year: 2011 ident: CR43 article-title: Weight gain, obesity, and psychotropic prescribing publication-title: J Obes doi: 10.1155/2011/893629 contributor: fullname: Megna – volume: 6 year: 2016 ident: CR7 article-title: Is increased antidepressant exposure a contributory factor to the obesity pandemic? publication-title: Transl Psychiatry doi: 10.1038/tp.2016.25 contributor: fullname: Wong – volume: 61 start-page: e565 year: 2011 end-page: 72 ident: CR5 article-title: Trends in primary care antidepressant prescribing 1995-2007: a longitudinal population database analysis publication-title: Br J Gen Pract doi: 10.3399/bjgp11X593848 contributor: fullname: Guthrie – volume: 72 start-page: 557 year: 1996 end-page: 66 ident: CR45 article-title: The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats publication-title: Neuroscience doi: 10.1016/0306-4522(95)00566-8 contributor: fullname: Williams – volume: 23 start-page: 549 year: 2003 end-page: 52 ident: CR44 article-title: African women with depression: the effect of imipramine and fluoxetine on body mass index and leptin secretion publication-title: J Clin Psychopharmacol doi: 10.1097/01.jcp.0000095341.32154.8f contributor: fullname: Joffe – volume: 62 start-page: 256 year: 2001 end-page: 60 ident: CR36 article-title: Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor-and imipramine-controlled trials publication-title: J Clin Psychiatry doi: 10.4088/JCP.v62n0407 contributor: fullname: Bikoff – volume: 8 start-page: 6 year: 2008 ident: CR23 article-title: The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome publication-title: BMC Cardiovasc Disord doi: 10.1186/1471-2261-8-6 contributor: fullname: Hayoz – ident: CR27 – volume: 35 start-page: 837 year: 1978 end-page: 44 ident: CR31 article-title: A diagnostic interview: the schedule for affective disorders and schizophrenia publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1978.01770310043002 contributor: fullname: Spitzer – volume: 26 start-page: 265 year: 1988 end-page: 71 ident: CR8 article-title: Antidepressant-induced weight gain: a comparison study of four medications publication-title: Psychiatry Res doi: 10.1016/0165-1781(88)90120-5 contributor: fullname: Kupfer – volume: 361 start-page: k1951 year: 2018 ident: CR13 article-title: Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study publication-title: BMJ doi: 10.1136/bmj.k1951 contributor: fullname: Gulliford – volume: 36 start-page: 1154 year: 2019 end-page: 62 ident: CR2 article-title: Depression increases the genetic susceptibility to high body mass index: Evidence from UK Biobank publication-title: Depress Anxiety doi: 10.1002/da.22963 contributor: fullname: Hypponen – volume: 9 year: 2009 ident: CR24 article-title: The PsyCoLaus study: methodology and characteristics of the sample of a population-based survey on psychiatric disorders and their association with genetic and cardiovascular risk factors publication-title: BMC Psychiatry doi: 10.1186/1471-244X-9-9 contributor: fullname: Vandeleur – volume: 156 start-page: 1170 year: 1999 end-page: 6 ident: CR37 article-title: Changes in weight during a 1-year trial of fluoxetine publication-title: Am J Psychiatry doi: 10.1176/ajp.156.8.1170 contributor: fullname: Zajecka – volume: 20 start-page: 208 year: 2012 end-page: 18 ident: CR17 article-title: Different anthropometric adiposity measures and their association with cardiovascular disease risk factors: a meta-analysis publication-title: Netherlands Heart J doi: 10.1007/s12471-011-0237-7 contributor: fullname: Wittink – volume: 34 start-page: 1229 year: 1977 end-page: 35 ident: CR34 article-title: The family history method using diagnostic criteria. Reliability and validity publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1977.01770220111013 contributor: fullname: Winokur – volume: 20 start-page: 1680 year: 2019 end-page: 90 ident: CR12 article-title: Effects of antidepressant and antipsychotic use on weight gain: a systematic review publication-title: Obes Rev doi: 10.1111/obr.12934 contributor: fullname: Marti – volume: 249 start-page: 174 year: 1999 end-page: 9 ident: CR30 article-title: Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version publication-title: Eur Arch Psychiatry Clin Neurosci doi: 10.1007/s004060050084 contributor: fullname: Ferrero – volume: 67 start-page: 220 year: 2010 end-page: 9 ident: CR3 article-title: Overweight, obesity, and depression a systematic review and meta-analysis of longitudinal studies publication-title: Arch Gen Psychiat doi: 10.1001/archgenpsychiatry.2010.2 contributor: fullname: Penninx – volume: 12 start-page: 1042 year: 2004 end-page: 9 ident: CR18 article-title: Body fat and fat-free mass and all-cause mortality publication-title: Obes Res doi: 10.1038/oby.2004.131 contributor: fullname: Heitmann – volume: 31 start-page: 756 year: 2007 end-page: 62 ident: CR25 article-title: Validity of the leg-to-leg bioimpedance to estimate changes in body fat during weight loss and regain in overweight women: a comparison with multi-compartment models publication-title: Int J Obes doi: 10.1038/sj.ijo.0803475 contributor: fullname: Prentice – volume: 18 start-page: 447 year: 2016 end-page: 57 ident: CR20 article-title: Sex differences in the psychopharmacological treatment of depression publication-title: Dialogues Clin Neurosci doi: 10.31887/DCNS.2016.18.4/ncutler contributor: fullname: Cutler – volume: 51 start-page: 849 year: 1994 end-page: 59 ident: CR28 article-title: Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1994.03950110009002 contributor: fullname: Harkavy-Friedman – volume: 100 start-page: 363 year: 2015 end-page: 70 ident: CR11 article-title: Clinical review: drugs commonly associated with weight change: a systematic review and meta-analysis publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2014-3421 contributor: fullname: Undavalli – volume: 76 start-page: e745 year: 2015 end-page: 51 ident: CR22 article-title: Sex-specific association between antidepressant use and body weight in a population-based study in older adults publication-title: J Clin Psychiatry doi: 10.4088/JCP.13m08896 contributor: fullname: Visser – volume: 33 start-page: 2611 year: 2010 end-page: 6 ident: CR38 article-title: Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study publication-title: Diabetes Care doi: 10.2337/dc10-1187 contributor: fullname: Pentti – volume: 208 start-page: 62 year: 2016 end-page: 68 ident: CR15 article-title: Six-year longitudinal course and outcomes of subtypes of depression publication-title: Br J Psychiatry doi: 10.1192/bjp.bp.114.153098 contributor: fullname: Penninx – volume: 23 start-page: 1443 year: 2013 end-page: 51 ident: CR21 article-title: Side effects of antidepressants during long-term use in a naturalistic setting publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2013.05.001 contributor: fullname: Hoogendijk – volume: 7 start-page: 133 year: 1984 end-page: 8 ident: CR35 article-title: Weight gain. A side-effect of tricyclic antidepressants publication-title: J Affect Disord doi: 10.1016/0165-0327(84)90031-4 contributor: fullname: Stern – volume: 315 start-page: 2230 year: 2016 end-page: 2 ident: CR6 article-title: Treatment Indications for antidepressants prescribed in primary care in Quebec, Canada, 2006-2015 publication-title: JAMA doi: 10.1001/jama.2016.3445 contributor: fullname: Tamblyn – ident: CR26 – volume: 241 start-page: 165 year: 1991 end-page: 9 ident: CR32 article-title: The reliability of the SADS-LA in a family study setting publication-title: Eur Arch Psychiatry Clin Neurosci doi: 10.1007/BF02219716 contributor: fullname: Franke – volume: 20 start-page: 63 year: 2018 end-page: 73 ident: CR1 article-title: Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications publication-title: Dialogues Clin Neurosci doi: 10.31887/DCNS.2018.20.1/bpenninx contributor: fullname: Lange – volume: 72 start-page: 557 year: 1996 ident: 3032_CR45 publication-title: Neuroscience doi: 10.1016/0306-4522(95)00566-8 contributor: fullname: S Dryden – volume: 9 year: 2009 ident: 3032_CR24 publication-title: BMC Psychiatry doi: 10.1186/1471-244X-9-9 contributor: fullname: M Preisig – volume: 71 start-page: 880 year: 2014 ident: 3032_CR16 publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2014.411 contributor: fullname: AM Lasserre – volume: 76 start-page: e745 year: 2015 ident: 3032_CR22 publication-title: J Clin Psychiatry doi: 10.4088/JCP.13m08896 contributor: fullname: R Noordam – volume: 10 start-page: 1511 year: 2009 ident: 3032_CR19 publication-title: Pharmacogenomics doi: 10.2217/pgs.09.102 contributor: fullname: S Haack – volume: 36 start-page: 1154 year: 2019 ident: 3032_CR2 publication-title: Depress Anxiety doi: 10.1002/da.22963 contributor: fullname: A Mulugeta – volume: 20 start-page: 63 year: 2018 ident: 3032_CR1 publication-title: Dialogues Clin Neurosci doi: 10.31887/DCNS.2018.20.1/bpenninx contributor: fullname: B Penninx – volume: 17 start-page: S37 issue: Suppl 1 year: 2002 ident: 3032_CR39 publication-title: Hum Psychopharmacol doi: 10.1002/hup.388 contributor: fullname: DJ Nutt – volume: 51 start-page: 849 year: 1994 ident: 3032_CR28 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1994.03950110009002 contributor: fullname: JI Nurnberger Jr – volume: 151 start-page: 737 year: 2007 ident: 3032_CR42 publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0707253 contributor: fullname: PK Gillman – volume: 8 start-page: 6 year: 2008 ident: 3032_CR23 publication-title: BMC Cardiovasc Disord doi: 10.1186/1471-2261-8-6 contributor: fullname: M Firmann – volume: 67 start-page: 220 year: 2010 ident: 3032_CR3 publication-title: Arch Gen Psychiat doi: 10.1001/archgenpsychiatry.2010.2 contributor: fullname: FS Luppino – volume: 249 start-page: 174 year: 1999 ident: 3032_CR30 publication-title: Eur Arch Psychiatry Clin Neurosci doi: 10.1007/s004060050084 contributor: fullname: M Preisig – ident: 3032_CR27 – volume: 5 start-page: 48 year: 2016 ident: 3032_CR41 publication-title: J Clin Med doi: 10.3390/jcm5040048 contributor: fullname: D Arterburn – volume: 78 start-page: 182 year: 2009 ident: 3032_CR14 publication-title: Psychother Psychosom doi: 10.1159/000209349 contributor: fullname: SB Patten – volume: 156 start-page: 1170 year: 1999 ident: 3032_CR37 publication-title: Am J Psychiatry doi: 10.1176/ajp.156.8.1170 contributor: fullname: D Michelson – volume: 20 start-page: 1680 year: 2019 ident: 3032_CR12 publication-title: Obes Rev doi: 10.1111/obr.12934 contributor: fullname: L Alonso-Pedrero – volume: 71 start-page: 889 year: 2014 ident: 3032_CR40 publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2014.414 contributor: fullname: SR Blumenthal – volume: 26 start-page: 265 year: 1988 ident: 3032_CR8 publication-title: Psychiatry Res doi: 10.1016/0165-1781(88)90120-5 contributor: fullname: MH Fernstrom – volume: 71 start-page: 1259 year: 2010 ident: 3032_CR10 publication-title: J Clin Psychiatry doi: 10.4088/JCP.09r05346blu contributor: fullname: A Serretti – volume: 20 start-page: 208 year: 2012 ident: 3032_CR17 publication-title: Netherlands Heart J doi: 10.1007/s12471-011-0237-7 contributor: fullname: SB van Dijk – volume: 62 start-page: 256 year: 2001 ident: 3032_CR36 publication-title: J Clin Psychiatry doi: 10.4088/JCP.v62n0407 contributor: fullname: N Sussman – volume: 33 start-page: 2611 year: 2010 ident: 3032_CR38 publication-title: Diabetes Care doi: 10.2337/dc10-1187 contributor: fullname: M Kivimaki – volume: 23 start-page: 1443 year: 2013 ident: 3032_CR21 publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2013.05.001 contributor: fullname: PM Bet – volume: 315 start-page: 2230 year: 2016 ident: 3032_CR6 publication-title: JAMA doi: 10.1001/jama.2016.3445 contributor: fullname: J Wong – volume: 34 start-page: 1229 year: 1977 ident: 3032_CR34 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1977.01770220111013 contributor: fullname: NC Andreasen – volume: 23 start-page: 549 year: 2003 ident: 3032_CR44 publication-title: J Clin Psychopharmacol doi: 10.1097/01.jcp.0000095341.32154.8f contributor: fullname: MY Moosa – volume: 65 start-page: 149 year: 2002 ident: 3032_CR29 publication-title: Drug Alcohol Depend doi: 10.1016/S0376-8716(01)00156-9 contributor: fullname: A Berney – ident: 3032_CR33 – volume: 7 start-page: 133 year: 1984 ident: 3032_CR35 publication-title: J Affect Disord doi: 10.1016/0165-0327(84)90031-4 contributor: fullname: GH Berken – volume: 208 start-page: 62 year: 2016 ident: 3032_CR15 publication-title: Br J Psychiatry doi: 10.1192/bjp.bp.114.153098 contributor: fullname: F Lamers – volume: 14 start-page: 367 year: 2011 ident: 3032_CR9 publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145710000933 contributor: fullname: R Uher – volume: 6 year: 2016 ident: 3032_CR7 publication-title: Transl Psychiatry doi: 10.1038/tp.2016.25 contributor: fullname: SH Lee – volume: 21 start-page: 51 year: 2016 ident: 3032_CR4 publication-title: Asian J Psychiatry doi: 10.1016/j.ajp.2015.12.008 contributor: fullname: M Mannan – volume: 12 start-page: 1042 year: 2004 ident: 3032_CR18 publication-title: Obes Res doi: 10.1038/oby.2004.131 contributor: fullname: J Bigaard – volume: 241 start-page: 165 year: 1991 ident: 3032_CR32 publication-title: Eur Arch Psychiatry Clin Neurosci doi: 10.1007/BF02219716 contributor: fullname: M Leboyer – volume: 61 start-page: e565 year: 2011 ident: 3032_CR5 publication-title: Br J Gen Pract doi: 10.3399/bjgp11X593848 contributor: fullname: P Lockhart – volume: 361 start-page: k1951 year: 2018 ident: 3032_CR13 publication-title: BMJ doi: 10.1136/bmj.k1951 contributor: fullname: R Gafoor – volume: 35 start-page: 837 year: 1978 ident: 3032_CR31 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1978.01770310043002 contributor: fullname: J Endicott – volume: 2011 year: 2011 ident: 3032_CR43 publication-title: J Obes doi: 10.1155/2011/893629 contributor: fullname: N Nihalani – volume: 18 start-page: 447 year: 2016 ident: 3032_CR20 publication-title: Dialogues Clin Neurosci doi: 10.31887/DCNS.2016.18.4/ncutler contributor: fullname: JJ Sramek – volume: 100 start-page: 363 year: 2015 ident: 3032_CR11 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2014-3421 contributor: fullname: JP Domecq – volume: 31 start-page: 756 year: 2007 ident: 3032_CR25 publication-title: Int J Obes doi: 10.1038/sj.ijo.0803475 contributor: fullname: SA Jebb – ident: 3032_CR26 |
SSID | ssj0000548171 |
Score | 2.4104345 |
Snippet | Research on antidepressant-related weight changes over more than 12 months is scarce and adjustment for the effects of depressive episodes has rarely been... Abstract Research on antidepressant-related weight changes over more than 12 months is scarce and adjustment for the effects of depressive episodes has rarely... |
SourceID | doaj swepub pubmedcentral proquest crossref pubmed springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 330 |
SubjectTerms | 631/443 692/699/476/1414 Adiposity - drug effects Adult Aged Antidepressants Antidepressive Agents - therapeutic use Behavioral Sciences Biological Psychology Body Mass Index Female Follow-Up Studies Humans Male Medicine Medicine & Public Health Middle Aged Neurosciences Pharmacotherapy Prospective Studies Psychiatry Selective Serotonin Reuptake Inhibitors - therapeutic use Waist Circumference |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5VPaBeEI8CgYKMVE4QNY4fiY-FUlWI9kRRb5YTO5ADWbSbPfTfM2Nntw2gcuFm5aE483C-iWe-ATiUgTiNBP13QzVIL0xeO8oyV6boguS-iv8hzy_02aX8dKWubrX6opywRA-cBHfUoDNS1yqtfYWxjnJNaLwJwnQ4dCLE1ZerW8FUYvWWNa_4VCVTiPpohas1VZOVMke7FhiBzb5EkbD_byjzz2TJ7Y7pb-yi8Yt0-gDuT1CSHadXeAg7YXgE986nzfLH4D8vhm85Lb0slfeuWD8w5_uYqHXNflBmznLFUqUic4NnsWM4jsZ-ypDFIUslWtfxZtamghK8nVrrLsd9uDz9-OXDWT41VchbqcyY4woVgi7bVlMzPlmFThVlJyqHwAljIa864mR3rtNKuFY3rS65M6Fs0bsLj3DwCewOiyE8A6ZMV8rK6ca1HYaJDWKtwJtK-EJ4h8LO4O1GwPZn4s6wcc9b1Dapw6I6bFSHVRm8Jx1sryTe63gArcFO1mD_ZQ0ZHGw0aCdnXFlRGAR6FNtl8Hp7Gt2I9kbcEBbrdA015zIyg6dJ4duZCMMR1yicYT0zhdlU52eG_nuk6uYU7CNCyuDdxmpu5nWXLN4ky5o94qT_ehylsV5bJSoM7Z__D5m9gL0yukWdc3EAu-NyHV4i0hqbV9GpfgGrvCVz priority: 102 providerName: Directory of Open Access Journals – databaseName: AUTh Library subscriptions: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3JbtUw0IJWQlwQOykFGQlOEDWJl8Qn1EKrCtEKIYp6s5zYKTmQtC95h_49M7ZfqgDqzcqiTDyLZx9C3nKHPY0Y-t0ADdwylVYGs8yFylrHc1t6P-TJqTw-41_OxXl0uI0xrXIjE72gtkODPvI9lik4rVFB_3h5leLUKIyuxhEad8l2kXMM024fHJ5--z57WUAhqfIyj9UyGav2RpDaWFVW8BTom4EltjiRfOP-_2mb_yZNzpHTv7qM-pPp6CF5EFVKuh9o4BG54_rH5N5JDJo_Ifbr0F-kKIJpKPMdaddTYzufsHVNf2OGzmqkoWKRmt5SPzkcVlMXM2VhSUOp1rV_mTahsARexxG7q-kpOTs6_PHpOI3DFdKGCzWlIKmck0XTSBzKx0vXiqxoWWlAgQKbyIoWe7Mb00rBTCPrRha5Ua5ogMszC2rhM7LVD717QahQbcFLI2vTtGAu1qBzubwumc2YNbDZCXm_2WB9GXpoaB_7ZpUO6NCADu3RoUVCDhAH85PY_9pfGFYXOrKTrkFE4ywzKS1AXwhTu9oqx1QLS8NcQnY3GNSRKUd9Q0IJeTPfBnbCGInp3bAOz-CQLsUT8jwgfIaEqRz0GwEQVgtSWIC6vNN3v3zL7hyNftCUEvJhQzU3cN22F-8CZS0-8bn7ue93Y73WgpVg4u_c_rsvyf3CE3yV5myXbE2rtXsFutRUv44M8we13R0z priority: 102 providerName: ProQuest – databaseName: SpringerOpen dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BkRAXxJu0BRkJThARx4_Ex7JQVYhyoqg3y4kdyIEs2s0e-u-ZsbNBgQqJm5XEycgz43zjeQG8lIFqGgk6d0M2SC9MXjuKMlem6ILkvornkOef9dmF_HipLqcyOZQLs_Dfi_rtFjdZSgIrZY7iKNBwugm3FNcFSfBKr-bzFIQeNa_4lBdz_dTFvyeW6L8OV_4dHjn7SP-oJxr_Qaf34O4EHtlJ4vZ9uBGGB3D7fHKPPwT_aT18y2mzZSmhd8v6gTnfx9CsK_aDYnE2W5ZyE5kbPIs9wnE09lNMLA5ZSsq6ipNZm1JIcDo1092Mj-Di9MOX1Vk-tVHIW6nMmOOeFIIu21ZT-z1ZhU4VZScqh1AJrR-vOqrC7lynlXCtblpdcmdC2aI-Fx4B4GM4GNZDeApMma6UldONazs0DBtEV4E3lfCF8A4XO4PX-wW2P1O1DBu93KK2iR0W2WEjO6zK4B3xYH6SKl3HCygAdlIc2-BmTF3LtPZIfalcExpvgjAdDp0IGRzvOWgn9dtaURiEdmTNZfBivo2KQ94QN4T1Lj1D7biMzOBJYvhMiTAckYxCCuuFKCxIXd4Z-u-xODcn8x4xUQZv9lLzm65_rcWrJFmLT7zvv57E1djtrBIVGvOH__faI7hTRgWocy6O4WDc7MIzRFFj8zyqzy8GnRSo priority: 102 providerName: Springer Nature |
Title | Long-term changes in adiposity markers during and after antidepressant therapy in a community cohort |
URI | https://link.springer.com/article/10.1038/s41398-024-03032-5 https://www.ncbi.nlm.nih.gov/pubmed/39138155 https://www.proquest.com/docview/3092500499 https://www.proquest.com/docview/3092869094/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC11322521 https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-537254 https://doaj.org/article/b1116ce266d74025abebd9e39f5aba3e |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1db9Mw8LQNadrLxPcyRmUkeIKsSRw78WNXNk0VnSZgqG-WEzsjEk2nNn3Yv-dsJ2UFxANPsfyhnHx39p3vC-BtamxOI2rf3RANqaYizJX1Mmciqkwa68y9Q06v-OVNOpmx2Q7wPhbGOe2XRX3a_JifNvV351t5Ny-HvZ_Y8Ho6ttXRE7x3hruwm1H6QEf3Gb3TPM7iLkImovlwhSe1jSRL0hBpmqL2dQD7VMR4W9kQvwcXksvb_zdh80-fyY3h9Lcko-5iungMh51ESUYe8iewY5qnsD_tbObPQH9aNLehPYGJj_JdkbohStfOX-uezK2DznJFfMAiUY0mrnA4ttq6c5TFJvGRWvduMSl9XAkutxV2l-1zuLk4_zq-DLvaCmGZMtGGeFAZw5Oy5LYmX5qZikVJRTOF8hOqRJpVNjW7UhVnVJW8KHkSK2GSEpk80igVvoC9ZtGYIyBMVEmaKV6oskJtsUCRy8RFRnVEtcJ9D-B9v8HyzqfQkM70TXPpMSMRM9JhRrIAziwONjNt-mvXsVjeyo4IZIEntC1lxrlG6BOmClNoYaiosKmoCeCkx6DseHIlaSRQ3rMqXgBvNsPITdZEohqzWPs5tkaXSAN46RG-gaQnmADyLVLYAnV7BAnYZezuCTaADz3V_ILrX3vxzlPW1i8-1t9GbjfWa8lohhr-8f9D9AoOEscXeRjTE9hrl2vzGsWsthggb82yATwajSZfJvg9O7-6_oy9Yz4euKeLgeO7nzFHKvA |
link.rule.ids | 230,315,733,786,790,870,891,2115,12083,21416,27955,27956,31752,31753,33777,33778,41153,42222,43343,43838,51609,53825,53827,74100,74657 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LbtQw0IIiARfEswQKGAlOEDWJ7SQ-ofKoFtjtqUV7s5zYKTmQlE320L9nxvamCqDerDyUiefheQ8hb7jFnkYM_W6ABm6YjEuNWeZCJo3lqSmcH3J1ki_O-Le1WAeH2xDSKncy0Qlq09foIz9kiYTTGhX0Dxe_Y5wahdHVMELjJrnFGeNI58W6mHwsoI6UaZGGWpmElYcDyGysKct4DNTNwA6bnUeubf__dM1_UyanuOlfPUbduXR8n9wLCiU98hTwgNyw3UNyexVC5o-IWfbdeYwCmPoi34G2HdWmdelal_QX5udsBurrFanuDHVzw2E1tiFPFpbUF2pdupdp7ctK4HUcsLsZH5Oz4y-nnxZxGK0Q11zIMQY5ZW2e1XWOI_l4YRuRZA0rNKhPYBEZ0WBndq2bXDBd51WdZ6mWNquBxxMDSuETstf1nX1KqJBNxgudV7puwFisQOOyaVUwkzCjYbMj8m63werCd9BQLvLNSuXRoQAdyqFDiYh8RBxMT2L3a3eh35yrwEyqAgGNk8zy3AD0mdCVrYy0TDaw1MxG5GCHQRVYclBXBBSR19NtYCaMkOjO9lv_DI7okjwi-x7hEyRMpqDdCICwnJHCDNT5na796Rp2p2jyg54Ukfc7qrmC67q9eOspa_aJz-2PI7cb260SrAAD_9n1v_uK3FmcrpZq-fXk-3NyN3PEX8YpOyB742ZrX4BWNVYvHev8AXH8Hro |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSBUXxJuUAkaCE0SbxLETn1ChrAq0FQeK9mY5sVNyIGk32UP_PTO2N1UA9WbloUw8D39jz4OQN7nFmkYM992ADblhMi41RplzmTQ2T03h9iFPTsXRWf51xVch_mkIYZVbm-gMtelr3CNfsETCao0AfdGEsIjvh8sPF5cxdpDCk9bQTuM2uQOrZIJtHIpVMe23ADQp0yINeTMJKxcD2G_ML8vyGCSdgU82W5tcCf__4c5_wyenM9S_6o26NWp5n9wL4JIeeGl4QG7Z7iHZPQnH54-IOe678xiNMfUJvwNtO6pN60K3ruhvjNVZD9TnLlLdGep6iMNobEPMLAypT9q6ci_T2qeYwOvYbHc9PiZny88_Ph3Foc1CXOdcjjHYLGtFVtcC2_PlhW14kjWs0AClwDsyvMEq7Vo3gjNdi6oWWaqlzWrQ98QAQHxCdrq-s88I5bLJ8kKLStcNOI4VoC-bVgUzCTMaJjsi77YTrC58NQ3lTsFZqTw7FLBDOXYoHpGPyIPpSayE7S7063MVFEtVYKyxq5kQBqjPuK5sZaRlsoGhZjYi-1sOqqCeg7oWpoi8nm6DYuFpie5sv_HPYLsumUfkqWf4RAmTKSAdDhSWM1GYkTq_07W_XPHuFN1_wEwReb-Vmmu6bpqLt16yZp84bH8euNnYbBRnBTj7ezf_7iuyC1qjjr-cfntO7mZO9ss4ZftkZ1xv7AsAWGP10mnOH-GKIuY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-term+changes+in+adiposity+markers+during+and+after+antidepressant+therapy+in+a+community+cohort&rft.jtitle=Translational+psychiatry&rft.au=Mwinyi%2C+Jessica&rft.au=Strippoli%2C+Marie-Pierre+F.&rft.au=Kanders%2C+Sofia+H.&rft.au=Schi%C3%B6th%2C+Helgi+B.&rft.date=2024-08-13&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2158-3188&rft.volume=14&rft.issue=1&rft_id=info:doi/10.1038%2Fs41398-024-03032-5&rft.externalDocID=10_1038_s41398_024_03032_5 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2158-3188&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2158-3188&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2158-3188&client=summon |